New Chemical Entities
Definition. A chemical entity is a physical entity of interest in chemistry including molecular entities, parts thereof, and chemical substances. New chemical entity. ... A new molecular entity (NME) is a drug that contains an active moiety that has never been
approved by the FDA or marketed in the US. It's important to note the difference between an NCE and a New Molecular Entity (NME). While an NCE has no active moiety, an NME contains an active moiety that has not yet been
approved by the FDA or marketed in the U.S. Preferred citation: These NCE-1 dates indicate the first opportunity for generic drug companies to file Abbreviated New Drug Applications (ANDAs) for generic entry into branded drug markets. Generic launch is dependent on many factors, including FDA approval and patents. Active moiety is the molecule or ion, excluding those appended portions of the molecule that cause the drug to be an ester, salt (including a salt with hydrogen or coordination bonds), or other noncovalent derivative (such as a complex, chelate, or clathrate) of the molecule, responsible for the physiologica. New chemical entity. A new chemical entity (NCE) is, according to the U.S. Food and Drug Administration, a drug that contains no active moiety that has been
approved by the FDA in any other application submitted under section 505(b) of the Federal Food, Drug, and Cosmetic Act.
High Impact List of Articles
-
A Unique Presentation Of Fahr Syndrome Secondary To Chronic Hypoparathyroidism: A Case Report
Alexander J Schupper & Michael M Chen
Case Report: Imaging in Medicine
-
A Unique Presentation Of Fahr Syndrome Secondary To Chronic Hypoparathyroidism: A Case Report
Alexander J Schupper & Michael M Chen
Case Report: Imaging in Medicine
-
A review on single coronary artery
Abhisekh Mohanty
Review Article: Imaging in Medicine
-
A review on single coronary artery
Abhisekh Mohanty
Review Article: Imaging in Medicine
-
Measuring patient satisfaction with the CT consent process: the COMRADE outcome measure
P Rogers, S Lloyd, D Shetty, P Newell
& D Gay
Special Report: Imaging in Medicine
-
Measuring patient satisfaction with the CT consent process: the COMRADE outcome measure
P Rogers, S Lloyd, D Shetty, P Newell
& D Gay
Special Report: Imaging in Medicine
-
3D optical coherence tomography for clinical diagnosis of nonmelanoma skin cancers
Aneesh Alex, Jessika Weingast, Bernd Hofer, Matthias Eibl, Michael Binder, Hubert Pehamberger, Wolfgang Drexler and Boris Povazay
Review Article: Imaging in Medicine
-
3D optical coherence tomography for clinical diagnosis of nonmelanoma skin cancers
Aneesh Alex, Jessika Weingast, Bernd Hofer, Matthias Eibl, Michael Binder, Hubert Pehamberger, Wolfgang Drexler and Boris Povazay
Review Article: Imaging in Medicine
-
Latest advances in cone-beam CT for bladder radiotherapy
Victoria A Harris, Fiona MA McDonald and Robert Huddart
Review Article: Imaging in Medicine
-
Latest advances in cone-beam CT for bladder radiotherapy
Victoria A Harris, Fiona MA McDonald and Robert Huddart
Review Article: Imaging in Medicine
-
Semantic web: key technologies for bridging imaging and translational medicine
Bernard Gibaud
Editorial: Imaging in Medicine
-
Semantic web: key technologies for bridging imaging and translational medicine
Bernard Gibaud
Editorial: Imaging in Medicine
Relevant Topics in General Science